The specialized portal Ciencia en Chile published an article highlighting the recent panel discussion “Early diagnosis and biomarkers: key topics at a panel discussion on Parkinson’s”, an event sponsored by CEDENNA and organized by the Universidad de Santiago de Chile.
The article highlights the focus of the event, centered on one of the main current challenges in addressing neurodegenerative diseases: moving towards earlier and more accurate diagnosis, based on the development of biomarkers and a better understanding of the biological mechanisms of Parkinson’s.
The panel brought together national and international specialists, who discussed topics such as the role of inflammation, the use of biomarkers such as alpha-synuclein and new diagnostic tools that seek to detect the disease before clinical symptoms appear. This point is especially relevant, considering that Parkinson’s is currently often diagnosed at late stages, when there is already significant neurological damage.
Along these lines, the article also highlights the interdisciplinary nature of the event, which linked basic and clinical science with the aim of moving towards concrete solutions for patients.
At CEDENNA, events like this are part of a strategy aimed at strengthening the link between frontier research and health applications, promoting the development of knowledge with real impact on the diagnosis and treatment of highly prevalent diseases.
? You can read the full article in Ciencia en Chile here:
https://www.cienciaenchile.cl/diagnostico-temprano-y-biomarcadores-claves-en-conversatorio-sobre-parkinson/
April 20, 2026
